Veracyte, Inc. (VCYT) Financials
VCYT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.5 billion | 98.0 million |
| March 31, 2026 | 1.4 billion | 92.0 million |
| Dec. 31, 2025 | 1.4 billion | 96.4 million |
| Sept. 30, 2025 | 1.4 billion | 110.1 million |
VCYT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 43.0 million | 14.1 million |
| March 31, 2026 | 32.3 million | 12.8 million |
| Dec. 31, 2025 | 48.3 million | 10.9 million |
| Sept. 30, 2025 | 42.0 million | 10.8 million |
VCYT Net Income
No data available :(
VCYT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 485.2 million | - | 40.1 million |
| March 31, 2026 | 439.1 million | - | 39.3 million |
| Dec. 31, 2025 | 412.9 million | - | 39.7 million |
| Sept. 30, 2025 | 366.4 million | - | 40.5 million |
VCYT Shares Outstanding
VCYT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2.9 million | 29.4 million | 55.7 million | 28.3 million |
| March 31, 2026 | 3.0 million | 27.1 million | 50.8 million | 27.2 million |
| Dec. 31, 2025 | 4.3 million | 20.8 million | 44.3 million | 42.9 million |
| Sept. 30, 2025 | 2.8 million | 16.0 million | 50.7 million | 7.5 million |
VCYT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 150.3 million | 41.8 million |
| March 31, 2026 | 139.1 million | 38.5 million |
| Dec. 31, 2025 | 140.6 million | 36.0 million |
| Sept. 30, 2025 | 131.9 million | 40.6 million |
VCYT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
VCYT
Price: $42.53
52 week price:
Earnings Per Share: 1.39 USD
P/E Ratio: 33.20
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 321710
Ebitda: -5.2 millionMarket Capitalization: 3.4 billion